Risk of fatal ICH with alteplase for stroke
{
"resourceType": "Evidence",
"id": "example-stroke-alteplase-fatalICH",
"text": {
"status": "generated",
"div": "<div xmlns=\"http://www.w3.org/1999/xhtml\">\n <p>\n "Risk of fatal ICH with alteplase for stroke" is a univariate risk estimate.\n </p>\n\t</div>"
},
"url": "http://hl7.org/fhir/Evidence/example-stroke-alteplase-fatalICH",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113883.4.642.10.1"
}
],
"title": "Risk of fatal ICH with alteplase for stroke",
"status": "draft",
"relatedArtifact": [
{
"type": "citation",
"label": "Emberson 2014",
"display": "Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.",
"citation": "Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063",
"document": {
"url": "https://doi.org/10.1016/S0140-6736(14)60584-5"
}
}
],
"description": "2.7% incidence of fatal intracranial hemorrhage within 7 days with alteplase in patients with acute ischemic stroke",
"variableDefinition": [
{
"variableRole": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/variable-role",
"code": "population",
"display": "population"
}
]
},
"observed": {
"reference": "Group/AcuteIschemicStroke",
"type": "Group",
"display": "adults with acute ischemic stroke"
},
"intended": {
"reference": "Group/AcuteIschemicStroke",
"type": "Group",
"display": "adults with acute ischemic stroke"
}
},
{
"variableRole": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/variable-role",
"code": "population",
"display": "population"
}
]
},
"observed": {
"reference": "Group/Emberson-2014-IPD-MA-Alteplase-Cohort",
"type": "Group",
"display": "Emberson 2014 IPD-MA Alteplase Cohort"
},
"intended": {
"reference": "Group/AcuteIschemicStrokeTreatedWithAlteplase",
"type": "Group",
"display": "adults with acute ischemic stroke treated with alteplase"
}
},
{
"variableRole": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/variable-role",
"code": "measuredVariable",
"display": "measured variable"
}
]
},
"observed": {
"reference": "EvidenceVariable/example-fatal-ICH-in-7-days",
"type": "EvidenceVariable",
"display": "fatal ICH"
},
"intended": {
"reference": "EvidenceVariable/example-fatal-ICH-in-7-days",
"type": "EvidenceVariable",
"display": "fatal ICH"
}
}
],
"synthesisType": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/synthesis-type",
"code": "IPD-MA",
"display": "individual patient data meta-analysis"
}
]
},
"studyDesign": [
{
"coding": [
{
"system": "http://hl7.org/fhir/research-study-classifiers",
"code": "SEVCO:01003",
"display": "randomized assignment"
}
]
}
],
"statistic": [
{
"statisticType": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/statistic-type",
"code": "C44256",
"display": "Proportion"
}
]
},
"quantity": {
"value": 0.026835741669
},
"numberOfEvents": 91,
"sampleSize": {
"numberOfStudies": 9,
"numberOfParticipants": 3391
}
}
]
}
Usage note: every effort has been made to ensure that the
examples are correct and useful, but they are not a normative part
of the specification.